Radio and PodcastRadio and PodcastLive Radio & Podcasts
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients artwork
Science & Medicine

Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients

Diabetes Discourse by ReachMD

Apr 8, 202400:11:30Science & Medicine

Host: Carol Wysham Guest: A. Michael Lincoff, MD Given the growing evidence that obesity is associated with increased cardiovascular risk, a recent study assessed the impact of semaglutide on cardiovascular outcomes in p...

About This Episode

Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients is an episode from Diabetes Discourse by ReachMD. Host: Carol Wysham Guest: A. Michael Lincoff, MD Given the growing evidence that obesity is associated with increased cardi...

Podcast

This episode belongs to Diabetes Discourse.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 8, 2024, 00:11:30 long, audio available.